These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder. Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N. Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846 [Abstract] [Full Text] [Related]
4. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands. Sasané R, Hodgkins P, Meijer W. Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165 [Abstract] [Full Text] [Related]
7. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]
11. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079 [Abstract] [Full Text] [Related]
14. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [Abstract] [Full Text] [Related]
15. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958 [Abstract] [Full Text] [Related]
16. Stimulant treatment over 5 years: effects on growth. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646 [Abstract] [Full Text] [Related]
17. Changes in medications administered in schools. McCarthy AM, Kelly MW, Johnson S, Roman J, Zimmerman MB. J Sch Nurs; 2006 Apr; 22(2):102-7. PubMed ID: 16563033 [Abstract] [Full Text] [Related]
18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
19. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, Rancurello M. J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969 [Abstract] [Full Text] [Related]
20. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007. Janols LO, Liliemark J, Klintberg K, von Knorring AL. Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]